BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bewersdorf JP, Zeidan AM. Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments? Cells 2020;9:E2310. [PMID: 33080779 DOI: 10.3390/cells9102310] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Pastore F, Pastore A, Rothenberg-Thurley M, Metzeler KH, Ksienzyk B, Schneider S, Bohlander SK, Braess J, Sauerland MC, Görlich D, Berdel WE, Wörmann B, von Bergwelt-Baildon MS, Hiddemann W, Spiekermann K. Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosis. Cancer 2022;128:4213-22. [PMID: 36271776 DOI: 10.1002/cncr.34495] [Reference Citation Analysis]
2 Reschke A, Richards RM, Smith SM, Long AH, Marks LJ, Schultz L, Kamens JL, Aftandilian C, Davis KL, Gruber T, Sakamoto KM. Development of clinical pathways to improve multidisciplinary care of high-risk pediatric oncology patients. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1033993] [Reference Citation Analysis]
3 Tada A, Kikuchi Y, Murase K, Takada K, Takasawa A. Drastic Multiorgan Dysfunction Due to Severe Leukostasis: A Case Report. Cureus 2022. [DOI: 10.7759/cureus.31518] [Reference Citation Analysis]
4 Cotorogea-Simion M, Pavel B, Isac S, Telecan T, Matache IM, Bobirca A, Bobirca FT, Rababoc R, Droc G. What Is Different in Acute Hematologic Malignancy-Associated ARDS? An Overview of the Literature. Medicina (Kaunas) 2022;58:1215. [PMID: 36143892 DOI: 10.3390/medicina58091215] [Reference Citation Analysis]
5 Gupta S, Gudsoorkar P, Jhaveri KD. Acute Kidney Injury in Critically Ill Patients with Cancer. Clin J Am Soc Nephrol 2022;17:1385-98. [PMID: 35338071 DOI: 10.2215/CJN.15681221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Mejía-buriticá L, Ocampo-medina M, Ospina-ospina S, Regino-agamez CA, Vásquez-palacio G, Torres-hernández JD. Caracterización clínica y citogenética de una cohorte de pacientes con leucemia promielocítica aguda atendidos en un Hospital Universitario en Medellín, Colombia. Med Lab 2022;26:273-286. [DOI: 10.36384/01232576.591] [Reference Citation Analysis]
7 Spring J, Munshi L. Hematology Emergencies in Adults With Critical Illness. Chest 2022;162:120-131. [DOI: 10.1016/j.chest.2022.02.004] [Reference Citation Analysis]
8 Hannarici Z, Yılmaz A, Buyukbayram ME, Turhan A, Tekin SB, Bilici M. Lipegfilgrastim may cause hyperleukocytosis. J Oncol Pharm Pract 2022;:10781552221082645. [PMID: 35200056 DOI: 10.1177/10781552221082645] [Reference Citation Analysis]
9 Fodil S, Arnaud M, Vaganay C, Puissant A, Lengline E, Mooney N, Itzykson R, Zafrani L. Endothelial cells: major players in acute myeloid leukaemia. Blood Reviews 2022. [DOI: 10.1016/j.blre.2022.100932] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Rinaldi I, Sutandyo N, Winston K. Comparison of early mortality between leukapheresis and non-leukapheresis in adult acute myeloid leukemia patients with hyperleukocytosis: a systematic review and meta-analysis. Hematology 2022;27:141-9. [DOI: 10.1080/16078454.2021.2024939] [Reference Citation Analysis]
11 Largeaud L, Bertoli S, Bérard E, Tavitian S, Picard M, Dufrechou S, Prade N, Vergez F, Rieu JB, Luquet I, Sarry A, Huguet F, Ruiz J, De Mas V, Delabesse E, Récher C. Genomic landscape of hyperleukocytic acute myeloid leukemia. Blood Cancer J 2022;12:4. [PMID: 34987148 DOI: 10.1038/s41408-021-00601-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Palmowski K, Sommerwerck U, Luft T. Pulmonale Manifestation hämatoonkologischer Erkrankungen und Therapien. Seltene Lungenerkrankungen 2022. [DOI: 10.1007/978-3-662-63651-0_37] [Reference Citation Analysis]
13 Bittar G, Oliveira-gomes DD, Rivero G, Baylor St. Luke's Medical Center, Houston, TX, USA, Baylor St. Luke's Medical Center, Houston, TX, USA, Baylor St. Luke's Medical Center, Houston, TX, USA, Section of Hematology and Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA, The Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA. Advances and Future Goals in Acute Myeloid Leukaemia Therapy. Oncology & Haematology 2022;18:130. [DOI: 10.17925/ohr.2022.18.2.130] [Reference Citation Analysis]
14 Lee KR, Paik JH, Lee SD, Kim M. Therapy-Related Acute Myeloid Leukemia Diagnosed at Postmortem in a Long-term Survivor of Advanced Hepatocellular Carcinoma. Korean J Leg Med 2021;45:139-144. [DOI: 10.7580/kjlm.2021.45.4.139] [Reference Citation Analysis]
15 Zhang XS, Gale RP, Huang XJ, Jiang Q. Is the Sokal or EUTOS long-term survival (ELTS) score a better predictor of responses and outcomes in persons with chronic myeloid leukemia receiving tyrosine-kinase inhibitors? Leukemia 2021. [PMID: 34413457 DOI: 10.1038/s41375-021-01387-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Rinaldi I, Sari RM, Tedhy VU, Winston K. Leukapheresis Does Not Improve Early Survival Outcome of Acute Myeloid Leukemia with Leukostasis Patients - A Dual-Center Retrospective Cohort Study. J Blood Med 2021;12:623-33. [PMID: 34290537 DOI: 10.2147/JBM.S312140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]